CAS 1812885-57-6

MNKI-85

CAS: 1812885-57-6

MNKI-85 is a small molecule that inhibits the activity of the mapk protein kinase and has minimal toxicity. MNKI-85 induces tumor regression in animal models and is being developed for the treatment of cancer. MNKI-85 induces apoptotic cell death by inhibiting translation, cellular transformation, and tumorigenesis. This drug also reduces leukemia cells by inhibiting protein synthesis and causing apoptotic cell death. Clinical trials are currently underway to assess the efficacy of this drug in patients with cancer.

Formel: C₂₀H₂₃FN₄O₃S

Reinheit: Min. 95%

Molekulargewicht: 418.49 g/mol

Ref: 3D-MXC88557